We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

115 hedge funds and large institutions have $152M invested in VanEck Biotech ETF in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $143M → $152M (+$8.83M)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

1% less funds holding

Funds holding: 116 → 115 (-1)

23.48% less ownership

Funds ownership: 101.82% → 78.34% (-23%)

28% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 29

Holders
115
Holders Change
-1
Holders Change %
-0.86%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
21
Reduced
29
Closed
9
Calls
$2.22M
Puts
–
Net Calls
+$2.22M
Net Calls Change
+$1.26M

Top Buyers

Rank Fund Capital Flow
1
IAIM
International Assets Investment Management
Florida
+$203M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.87M
3
Goldman Sachs
Goldman Sachs
New York
+$1.91M
4
Jane Street
Jane Street
New York
+$1.19M
5
Wells Fargo
Wells Fargo
California
+$567K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.55M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.43M
3
ACA
Atlas Capital Advisors
Wyoming
-$960K
4
MIM
Miller Investment Management
Pennsylvania
-$745K
5
Bank of America
Bank of America
North Carolina
-$572K
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
26
Stifel Financial
Missouri
$1.19M -$10.1K -57 -0.8%
RJA
27
Raymond James & Associates
Florida
$1.11M -$6.21K -35 -0.6%
Cerity Partners
28
Cerity Partners
New York
$1.08M – – –
PSF
29
Pacific Sun Financial
California
$1.01M -$26.6K -150 -3%
KAS
30
Kestra Advisory Services
Texas
$961K -$34.1K -192 -3%
CIBC Private Wealth Group
31
CIBC Private Wealth Group
Georgia
$880K – – –
Wealthfront Advisers
32
Wealthfront Advisers
California
$805K +$8.87K +50 +1%
AL
33
Aspiriant LLC
California
$769K – – –
Ameriprise
34
Ameriprise
Minnesota
$748K -$16.9K -95 -2%
PNC Financial Services Group
35
PNC Financial Services Group
Pennsylvania
$710K – – –
NWA
36
Navis Wealth Advisors
New York
$700K – – –
AssetMark Inc
37
AssetMark Inc
California
$615K -$5.68K -32 -0.9%
Envestnet Asset Management
38
Envestnet Asset Management
Illinois
$576K +$86.6K +488 +18%
Kovitz Investment Group Partners
39
Kovitz Investment Group Partners
Illinois
$565K +$25K +141 +5%
PWP
40
Pursue Wealth Partners
California
$532K – – –
Truist Financial
41
Truist Financial
North Carolina
$484K +$4.61K +26 +1%
Jones Financial Companies
42
Jones Financial Companies
Missouri
$481K +$9.23K +52 +2%
Two Sigma Investments
43
Two Sigma Investments
New York
$461K +$461K +2,600 New
Wealth Enhancement Advisory Services
44
Wealth Enhancement Advisory Services
Minnesota
$403K -$4.79K -27 -1%
Cetera Investment Advisers
45
Cetera Investment Advisers
Illinois
$402K +$12.8K +72 +3%
WJWM
46
Williams Jones Wealth Management
New York
$390K – – –
PVI
47
Pine Valley Investments
New Jersey
$385K – – –
LFAS
48
Level Four Advisory Services
Texas
$368K – – –
TRCT
49
Tower Research Capital (TRC)
New York
$336K +$78.2K +441 +30%
PAG
50
Private Advisor Group
New Jersey
$333K – – –
1
2
3 4 5

BBH Hedge Fund Activity: Q3 2024 in Review

115 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2024, worth a combined $152M — up 6.2% from $143M a quarter earlier.

Fund positioning in BBH was balanced in Q3 2024: 9 funds opened new positions, 9 closed out, 21 added to existing stakes and 29 trimmed.

The largest buyer was International Assets Investment Management, adding an estimated $203M. The largest seller was Susquehanna International Group, cutting an estimated $1.55M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2024, down from 116 in Q2 2024.
  • Funds reported $152M of VanEck Biotech ETF stock for Q3 2024, up 6.2% quarter-over-quarter.
  • 9 funds opened new VanEck Biotech ETF positions in Q3 2024 and 9 closed out, a net change of 0 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2024 was International Assets Investment Management, an estimated $203M added.
  • The largest VanEck Biotech ETF seller in Q3 2024 was Susquehanna International Group, an estimated $1.55M sold.

Based on aggregated 13F filings for Q3 2024.